CARL
LIVE

Serial Number

99815821

Owner

ResuSciTec GmbH

Attorney

Alan Edwin Schiavelli

Filing Date

May 11, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CARL Trademark

Serial Number: 99815821

CARL is a trademark filed by ResuSciTec GmbH on May 11, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 45 (Legal & Security Services). The application is currently pending registration.

Owner Contact Info

ResuSciTec GmbH (17 trademarks)

Engesserstr. 4a

Entity Type: 16

Trademark Details

Filing Date

May 11, 2026

Registration Date

Not Registered

Goods & Services

Measuring, detecting and monitoring instruments, indicators and controllers for measuring, detecting, and monitoring electrical, physiological and chemical properties of biological organism, including a human or an animal for scientific research uses; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication, namely, medical drugs, blood or blood substitute for influencing physiological and chemical blood properties; electronic indicator panels for indicating body activity and function of a human or an animal; electric monitoring units for monitoring body activities of a human or an animal for scientific research uses; electric monitoring control apparatus for monitoring and controlling body activity and function of a human or an animal, including cardiac activity for scientific research uses

Physical therapy equipment for cardio training being ergometer, bicycle ergometer, indoor cycles, treadmill, cross-trainer, rowing machine ergometer, stepper device; physiotherapy and rehabilitation equipment, namely, shoulder stretcher using resistance cables, treadmills, stepper, and indoor bicycles; apparatus for the therapeutic stimulation of the muscles, including the heart muscle by applying electrodes on the chest; body rehabilitation apparatus for medical purposes, namely, cardio training devices

Medical preparations, namely, for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, and for resuscitation; pharmaceuticals preparations for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, and for the purpose of resuscitation; diagnostic preparations for medical use for detecting physiological and blood-specific properties of a human and an animal; medical dressings and medical plasters for cover and reseal of wounds, and medical syringes prefilled with medical drugs for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, in particular for resuscitation; blood for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, in particular for resuscitation; blood substitute for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, in particular for resuscitation; biological preparations for medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, and for resuscitation; blood for medical purposes; blood components for medical purposes for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, and for resuscitation; blood substitutes for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, stroke, and for resuscitation; blood plasma; enzyme preparations for medical purposes; solidified oxygen for medical use; gases for medical purposes; gas mixtures for medical use; haemoglobin; cooling sprays for medical purposes; radioactive substances for medical purposes; solidified gases for medical purposes

Investigation and surveillance services relating to the physical safety of persons and security of tangible property

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 30, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 30, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 30, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 30, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 30, 2026 CNEA
ASSIGNED TO EXAMINER
Jul 27, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
May 11, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2026 NWOS
NEW APPLICATION ENTERED
May 11, 2026 NWAP